Tokyo--August 25, 2026--Hakuhodo DY Holdings Inc.'s Industrial Architecture Strategy Division and Corundum Systems Biology Inc., a global venture capital firm connecting the world's most advanced science with Japanese companies, will jointly host the 7th Global Deep Tech VC Seminar, part of a seminar series that supports open innovation and new business creation at major Japanese companies.
The session will feature Vikram Ramasubramanian, an investor and operator with more than 20 years of experience across venture capital, operations, strategy, and private equity and venture capital (PE/VC) advisory. Drawing on his experience leading more than 50 investments, from seed to series B, and managing a portfolio of more than 250 startups, he will examine the changes now under way in India's private equity and venture capital markets. He will look at how the market appears differently depending on sector, region, company stage and investor type, and discuss what Japanese companies should keep in mind when considering business development, investment, or collaboration in India.
The webinar is intended for professionals in corporate strategy, R&D, investment and new business development at Japanese companies who are considering business, investment, or collaboration with local partners in India.
Event Background
The Global Deep Tech VC Seminar brings on-the-ground insights from international researchers, startups and investors to Japanese companies, with a focus on applying these in new business development, investment and collaboration. Past sessions have covered themes such as global VC trends, hard tech investment and US-Japan cross-border investment.
In recent years, ties between Japan and India have deepened, and Japanese companies are paying growing attention to the Indian market. At the same time, India is a vast market where many cultures and languages coexist, which makes it difficult to grasp from the outside and prone to misconceptions. Rather than treating India as a single market, this session will break it down by sector, region, company stage and investor type, and offer practical perspectives for Japanese companies considering business development, investment, or collaboration in India.
About the Global Deep Tech VC Seminar
The Global Deep Tech VC Seminar is a seminar series co-hosted by Hakuhodo DY Holdings and Corundum Systems Biology, focusing on the forefront of global investment in frontier technologies. It invites leading international venture capital firms and experts to share insights on how Japanese companies can engage with cutting-edge fields.
7th Global Deep Tech VC Seminar: India's Private Equity and Venture Capital Markets-- An On-the-Ground Perspective
- Co-hosts: Hakuhodo DY Holdings Inc.'s Industrial Architecture Strategy Division and Corundum Systems Biology Inc.
- Featured speaker: Vikram Ramasubramanian
- Date and time: 12:00 noon to 1:30 pm (Japan Standard Time) / 8:30 to 10:00 am (India Standard Time), Thursday, September 17, 2026
- Duration: 90 minutes
- Format: Streamed live online (Zoom webinar)
- Participation: Free (advance registration required)
- Application deadline: 6:00 pm (Japan Standard Time) / 2:30 pm (India Standard Time), Wednesday, September 16, 2026
- Where to sign up: https://us06web.zoom.us/webinar/register/WN_sSrE4lkJTgGvUq0o2e8Jlg
- Inquiries about the seminar:
Industrial Architecture Strategy Division, Hakuhodo DY Holdings Inc. https://docs.google.com/forms/d/e/1FAIpQLSdTZtoNUBXji78kD_-9WZjHmc8Bi2B5sSA60NNrJzdWyDf4xA/viewform
Program (Provisional)
- Opening remarks (introduction and session guidance)
- Presentation by Vikram Ramasubramanian (approximately 40 to 45 minutes)
- Moderated discussion with Sou Miyake, Head of Venture Investment, Corundum Systems Biology (approximately 20 minutes)
Audience Q&A The program and timing are subject to change.
Speaker
Vikram Ramasubramanian
Investor and operator with more than 20 years of experience across venture capital, operations, strategy, and private equity and venture capital (PE/VC) advisory. He has led more than 50 early-stage investments from seed to series B across sectors and regions, and managed a portfolio of more than 250 startups. He built post-investment support programs and early-warning systems and helped turn around six startups. Previously, as a Director at KPMG India, he advised PE/VC investors and companies on due diligence, value creation, integrations, carve-outs and transaction strategy. He is a Chartered Accountant (ICAI).
Moderator
Sou Miyake (Head of Venture Investment, Corundum Systems Biology / Moderator for this session)
As Head of Venture Investment at Corundum Systems Biology, Miyake leads global investment activities in systems biology, a field that integrates biology, AI and engineering, working on themes spanning therapeutics, consumer health, preventive medicine and the integration of Eastern and Western medicine. His career bridges science and business globally, including strategy work for pharmaceutical and FMCG clients at L.E.K. Consulting in Japan, launching a Japan cross-border business at Shopee in Singapore, and a PhD in molecular microbiology from King Abdullah University of Science and Technology (KAUST) in Saudi Arabia.
About Corundum Systems Biology
Company: Corundum Systems Biology Inc.
Address: 1st Fl., Hiroo Town House, 3-14-24 Hiroo, Shibuya-ku, Tokyo
Representative: Hidehiko Otake, CEO
Corundum Systems Biology is a venture capital firm established in 2020 dedicated to promoting health-related research and business creation by supporting innovative startups in systems biology, with the aim of contributing to breakthrough advances in health and wellbeing. Its team provides expertise to support the long-term growth of portfolio companies, along with access to broad industry and scientific networks and proprietary health data. The Corundum Group also has offices in the United States and Israel, supports research through a nonprofit organization and invests in the field of brain and neuroscience.